MTOR and ovarian carcinoma: Therefore, our illustration demonstrated that cRGD inhibited VM formation in ovarian cancer via not only down-regulating uPA expression which reduced MMP-2 efficiency to cleave Laminin5γ2 through AKT/mTOR/MMP-2/Laminin5γ2 signal pathway but also reducing EMT (Figure 8).